These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 20889902
41. Risk of incident active tuberculosis and use of corticosteroids. Lai CC, Lee MT, Lee SH, Lee SH, Chang SS, Lee CC. Int J Tuberc Lung Dis; 2015 Aug; 19(8):936-42. PubMed ID: 26162360 [Abstract] [Full Text] [Related]
42. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease. Pujades-Rodríguez M, Smith CJ, Hubbard RB. QJM; 2007 Aug; 100(8):509-17. PubMed ID: 17609226 [Abstract] [Full Text] [Related]
43. Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study. Roede BM, Bresser P, Bindels PJ, Kok A, Prins M, ter Riet G, Geskus RB, Herings RM, Prins JM. Thorax; 2008 Nov; 63(11):968-73. PubMed ID: 18682520 [Abstract] [Full Text] [Related]
44. No evidence that early use of inhaled corticosteroids reduces current asthma at 10 years of age. Devulapalli CS, Lødrup Carlsen KC, Håland G, Munthe-Kaas MC, Pettersen M, Mowinckel P, Carlsen KH. Respir Med; 2007 Aug; 101(8):1625-32. PubMed ID: 17513101 [Abstract] [Full Text] [Related]
45. Corticosteroids and the risk of atrial fibrillation. van der Hooft CS, Heeringa J, Brusselle GG, Hofman A, Witteman JC, Kingma JH, Sturkenboom MC, Stricker BH. Arch Intern Med; 2006 May 08; 166(9):1016-20. PubMed ID: 16682576 [Abstract] [Full Text] [Related]
46. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization. Gagnon YM, Levy AR, Spencer MD, Hurley JS, Frost FJ, Mapel DW, Briggs AH. Respir Med; 2005 Dec 08; 99(12):1534-45. PubMed ID: 16291076 [Abstract] [Full Text] [Related]
47. Effect of inhaled corticosteroids on forearm bone mineral density: the HUNT study, Norway. Langhammer A, Forsmo S, Lilleeng S, Johnsen R, Bjermer L. Respir Med; 2007 Aug 08; 101(8):1744-52. PubMed ID: 17433653 [Abstract] [Full Text] [Related]
48. Cigarette smoking and its relation to pulmonary tuberculosis in adults. Ariyothai N, Podhipak A, Akarasewi P, Tornee S, Smithtikarn S, Thongprathum P. Southeast Asian J Trop Med Public Health; 2004 Mar 08; 35(1):219-27. PubMed ID: 15272772 [Abstract] [Full Text] [Related]
49. Treatment persistence with leukotriene receptor antagonists and inhaled corticosteroids. Dorais M, Blais L, Chabot I, LeLorier J. J Asthma; 2005 Jun 08; 42(5):385-93. PubMed ID: 16036414 [Abstract] [Full Text] [Related]
50. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population. Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM. Curr Med Res Opin; 2009 Sep 08; 25(9):2251-8. PubMed ID: 19622006 [Abstract] [Full Text] [Related]
51. Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies. Chalitsios CV, Shaw DE, McKeever TM. Thorax; 2021 Jan 08; 76(1):21-28. PubMed ID: 33087546 [Abstract] [Full Text] [Related]
52. Incidence of tuberculosis and the importance of treatment of latent tuberculosis infection in a Spanish prison population. Martin V, Guerra JM, Cayla JA, Rodriguez JC, Blanco MD, Alcoba M. Int J Tuberc Lung Dis; 2001 Oct 08; 5(10):926-32. PubMed ID: 11605886 [Abstract] [Full Text] [Related]
53. [Current epidemiological situation of tuberculosis in the workplace: considering the risk of tuberculosis among nurses]. Ohmori M, Hoshino H, Yamauchi Y, Uchimura K. Kekkaku; 2007 Feb 08; 82(2):85-93. PubMed ID: 17373317 [Abstract] [Full Text] [Related]
54. Severity of obstructive airway disease and risk of osteoporotic fracture. de Vries F, van Staa TP, Bracke MS, Cooper C, Leufkens HG, Lammers JW. Eur Respir J; 2005 May 08; 25(5):879-84. PubMed ID: 15863646 [Abstract] [Full Text] [Related]
55. Long-term Use of Inhaled Corticosteroids in COPD and the Risk of Fracture. Gonzalez AV, Coulombe J, Ernst P, Suissa S. Chest; 2018 Feb 08; 153(2):321-328. PubMed ID: 28716642 [Abstract] [Full Text] [Related]
56. Use of inhaled corticosteroids and risk of fractures. van Staa TP, Leufkens HG, Cooper C. J Bone Miner Res; 2001 Mar 08; 16(3):581-8. PubMed ID: 11277277 [Abstract] [Full Text] [Related]
57. Inhaled corticosteroid is associated with an increased risk of TB in patients with COPD. Kim JH, Park JS, Kim KH, Jeong HC, Kim EK, Lee JH. Chest; 2013 Apr 08; 143(4):1018-1024. PubMed ID: 23079688 [Abstract] [Full Text] [Related]
58. Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study. Lee CH, Lee MC, Shu CC, Lim CS, Wang JY, Lee LN, Chao KM. BMC Infect Dis; 2013 Apr 30; 13():194. PubMed ID: 23631563 [Abstract] [Full Text] [Related]
59. Associated factors for tuberculosis recurrence in Taiwan: a nationwide nested case-control study from 1998 to 2010. Hung CL, Chien JY, Ou CY. PLoS One; 2015 Apr 30; 10(5):e0124822. PubMed ID: 25932917 [Abstract] [Full Text] [Related]
60. Inhaled corticosteroids (ICS) and risk of mycobacterium in patients with chronic respiratory diseases: a meta-analysis. Ni S, Fu Z, Zhao J, Liu H. J Thorac Dis; 2014 Jul 30; 6(7):971-8. PubMed ID: 25093095 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]